CGS vs CMP

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

58MEDIUM

CMP

COMPUMEDIC FPO [CMP]

56MEDIUM

Score Breakdown

CGS CMP
Technical
47
42
Catalyst
53
50
Sentiment
50
50
Fundamental
96
90
Momentum
79
55
Risk Gate
50
50

Key Metrics

CGS Metric CMP
$489.3MMarket Cap$45.9M
397KAvg Volume (20d)64K
+0.1%Short InterestN/A
$3.01052-Week High$0.450
$1.55052-Week Low$0.220
-3.5%Daily Change+0.0%
$2.780Reference Price$0.230
+22.5%ROE+0.5%
+19.2%Profit Margin+0.2%

Active Signals

CGS Signals

MACD crossed bearish — momentum is fading
Volume surging at 2.4x normal while price falls — heavy selling pressure
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Moderate P/S ratio (8.7x)
Moderate revenue growth (+12%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

CMP Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Drifting lower — down 9.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.8x)

Ask Scout AI to compare CGS and CMP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs IMM →CGS vs LDX →CGS vs NTI →CGS vs NYR →CMP vs EMD →
CGS Full Analysis → CMP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).